[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342650-105":59,"doc-detail-342650-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-effect-of-hmgb1-and-hmgb2-on-transcriptional-regulation-differs-in-neuroendocrine-and-adenocarcinoma-models-of-prostate-cancer","The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer","","Human high-mobility group-B (HMGB) proteins regulate gene expression in prostate cancer (PCa), including aggressive forms that fail hormonal treatment. The study examined how HMGB1 and HMGB2 silencing alters expression of PCa-associated genes in PC-3 neuroendocrine models and LNCaP adenocarcinoma models. Most analyzed genes (72%) responded, with HMGB1 acting mainly as a repressor and HMGB2 as an activator. SERPINE1, CDK1, ZWINT, and FN1 changes were confirmed by qRT-PCR after HMGB1 manipulation, and HMGB2 regulatory effects differed between cell lines. Target correlations were assessed in patient samples and neuroendocrine subgroups, supporting biomarker discovery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-effect-of-hmgb1-and-hmgb2-on-transcriptional-regulation-differs-in-neuroendocrine-and-adenocarcinoma-models-of-prostate-cancer/342650/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-effect-of-hmgb1-and-hmgb2-on-transcriptional-regulation-differs-in-neuroendocrine-and-adenocarcinoma-models-of-prostate-cancer/342650.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of analyzing HMGB1 and HMGB2 in prostate cancer?","Question",{"text":112,"@type":113},"To determine how HMGB1 and HMGB2 influence transcriptional regulation and how their roles differ between neuroendocrine and adenocarcinoma models of prostate cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did HMGB1 and HMGB2 behave with respect to gene regulation in the PC-3 model?",{"text":117,"@type":113},"HMGB1 mostly acted as a repressor, whereas HMGB2 functioned primarily as an activator of gene expression.",{"name":119,"@type":110,"acceptedAnswer":120},"Which experimental approaches were used to validate HMGB-related gene expression changes?",{"text":121,"@type":113},"The effects of HMGB1 or HMGB2 silencing/overexpression were assessed using pre-designed primer panels and validated by qRT-PCR in PC-3 and LNCaP cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342650,1790170959,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nThe Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer  \nMartín Salamini-Montemurri 1,2,3, Ángel Vizoso-Vázquez 1,2,3, Aida Barreiro-Alonso 1,2,3, Lidia Lorenzo-Catoira 1,2,3, Esther Rodríguez-Belmonte 1,2,3, María-Esperanza Cerdán 1,2,3, * and Mónica Lamas-Maceiras 1,2,3, *  \nCitation: Salamini-Montemurri, M.; Vizoso-Vázquez, Á .; Barreiro-Alonso, A.; Lorenzo-Catoira, L.;  \nRodríguez-Belmonte, E.; Cerdán, M.-E.; Lamas-Maceiras, M. The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer. Int. J. Mol. Sci. 2024, 25, 3106. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25063106](10.3390/ijms25063106)  \nAcademic Editor: Noriyuki Koibuchi  \nReceived: 23 January 2024  \nRevised: 25 February 2024  \nAccepted: 5 March 2024  \nPublished: 7 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Centro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain; [martin.salamini.montemurri@udc.es](martin.salamini.montemurri@udc.es) (M.S.-M.);  \n[a.vizoso@udc.es](a.vizoso@udc.es) (Á .V.-V.); [aida.barreiro@udc.es](aida.barreiro@udc.es) (A.B.-A.); [lidia.lorenzo.catoira@udc.es](lidia.lorenzo.catoira@udc.es) (L.L.-C.);  \nesther.belmonte@udc.es (E.R.-B.)  \n2 Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Fraga, s/n,  \n15071 A Coruña, Spain  \n3 Instituto de Investigación Biomédica de A Coruña (INIBIC), As Xubias de Arriba 84, 15006 A Coruña, Spain  \n* Correspondence: esper.cerdan@udc.es (M.-E.C.); mlamas@udc.es (M.L.-M.)  \nAbstract: Human high-mobility group-B (HMGB) proteins regulate gene expression in prostate cancer (PCa), a leading cause of oncological death in men. Their role in aggressive PCa cancers, which do not respond to hormonal treatment, was analyzed. The effects of HMGB1 and HMGB2 silencing upon the expression of genes previously related to PCa were studied in the PCa cell line PC-3 (selected as a small cell neuroendocrine carcinoma, SCNC, PCa model not responding to hormonal treatment) . A total of 72% of genes analyzed, using pre-designed primer panels, were affected. HMGB1 behaved mostly as a repressor, but HMGB2 as an activator. Changes in SERPINE1, CDK1, ZWINT, and FN1 expression were validated using qRT-PCR after HMGB1 silencing or overexpression in PC-3 and LNCaP (selected as an adenocarcinoma model of PCa responding to hormonal treatment) cell lines. Similarly, the regulatory role of HMGB2 upon SERPINE1, ZWINT, FN1, IGFPB3, and TYMS expression was validated, finding differences between cell lines. The correlation between the expression of HMGB1, HMGB2, and their targets was analyzed in PCa patient samples and also in PCa subgroups, classified as neuroendocrine positive or negative, in public databases. These results allow a better understanding of the role of HMGB proteins in PCa and contribute to find specific biomarkers for aggressive PCa.  \nKeywords: HMGB proteins; SERPINE1; ZWINT; FN1; IGBPB3; TYMS; CDK1; neuroendocrine prostatic cancer; transcriptional regulation  \n1. Introduction  \nProstate cancer (PCa) is the second most commonly diagnosed cancer and the fifth leading cause of cancer death among men worldwide, with 1,414,000 new cancer cases and 375,304 deaths reported in 2020 [1] . PCa incidence rates decreased dramatically between 2007 and 2014 due to prostate-specific antigen (PSA) testing. But since 2014, the incidence rates of PCa have increased by 3% each year [1] . The accumulation of inherited or acquired mutations, a","cbCaicZ2tfucqsIr","https://ap.wps.com/l/cbCaicZ2tfucqsIr","pdf",3869256,13,"English","# Abstract\n# Introduction\n# Methods (Gene Silencing and Expression Analysis)\n## qRT-PCR Validation\n## Cell Models and Gene Panels\n# Results (HMGB1 vs HMGB2 Regulatory Roles)\n# Results (Target Validation and Cell-Line Differences)\n# Results (Patient Sample Correlations and Neuroendocrine Subgroups)\n# Conclusions and Biomarker Implications","[{\"question\":\"What was the main goal of analyzing HMGB1 and HMGB2 in prostate cancer?\",\"answer\":\"To determine how HMGB1 and HMGB2 influence transcriptional regulation and how their roles differ between neuroendocrine and adenocarcinoma models of prostate cancer.\"},{\"question\":\"How did HMGB1 and HMGB2 behave with respect to gene regulation in the PC-3 model?\",\"answer\":\"HMGB1 mostly acted as a repressor, whereas HMGB2 functioned primarily as an activator of gene expression.\"},{\"question\":\"Which experimental approaches were used to validate HMGB-related gene expression changes?\",\"answer\":\"The effects of HMGB1 or HMGB2 silencing/overexpression were assessed using pre-designed primer panels and validated by qRT-PCR in PC-3 and LNCaP cell lines.\"}]","The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer | PDF",1790047544,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79823c1cc2c10d8b777d6bd37607f7d4.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64dc28bb73dcd10bedcc8b3013d9b2ac.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a37198268bc3fd57e3f1fce72274d72.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b621e43970b1110cbf8ec01b07b5809.webp",980,1385]